PT1377574E - 6-fenilbenzonaftiridinas - Google Patents
6-fenilbenzonaftiridinasInfo
- Publication number
- PT1377574E PT1377574E PT02722110T PT02722110T PT1377574E PT 1377574 E PT1377574 E PT 1377574E PT 02722110 T PT02722110 T PT 02722110T PT 02722110 T PT02722110 T PT 02722110T PT 1377574 E PT1377574 E PT 1377574E
- Authority
- PT
- Portugal
- Prior art keywords
- phenylbenzone
- pyridines
- pde3
- inhibitors
- compounds
- Prior art date
Links
- 101100135868 Dictyostelium discoideum pde3 gene Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electroluminescent Light Sources (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01104086 | 2001-02-21 | ||
| PCT/EP2002/001819 WO2002066476A1 (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1377574E true PT1377574E (pt) | 2005-05-31 |
Family
ID=8176545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02722110T PT1377574E (pt) | 2001-02-21 | 2002-02-21 | 6-fenilbenzonaftiridinas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6936622B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1377574B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4248245B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE287403T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2002253045B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2438717C (cg-RX-API-DMAC10.html) |
| DE (1) | DE60202669T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK1377574T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2236504T3 (cg-RX-API-DMAC10.html) |
| PT (1) | PT1377574E (cg-RX-API-DMAC10.html) |
| SI (1) | SI1377574T1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2002066476A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS20050116A (sr) * | 2002-08-17 | 2007-11-15 | Altana Pharma Ag., | Novi fenantridini |
| EP1581533A2 (en) * | 2002-08-17 | 2005-10-05 | ALTANA Pharma AG | Novel benzonaphthyridines |
| JP4587295B2 (ja) | 2002-08-29 | 2010-11-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４インヒビターとしての３−ヒドロキシ−６−フェニルフェナントリジン |
| HRP20050293A2 (en) | 2002-09-04 | 2006-07-31 | Altana Pharma Ag | Novel benzonaphthyridines |
| AU2003264132B2 (en) * | 2002-09-04 | 2009-11-19 | Takeda Gmbh | Novel benzonaphthyridines |
| EP1720835B1 (en) * | 2004-02-18 | 2012-12-12 | Nycomed GmbH | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| HRP20130828T1 (en) * | 2004-03-03 | 2013-09-30 | Takeda Gmbh | Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors |
| AU2005221832A1 (en) * | 2004-03-10 | 2005-09-22 | Nycomed Gmbh | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors |
| US7671068B2 (en) | 2004-03-17 | 2010-03-02 | Nycomed Gmbh | N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors |
| MX2007010400A (es) * | 2005-03-02 | 2008-01-11 | Nycomed Gmbh | Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo. |
| WO2018069210A1 (en) | 2016-10-10 | 2018-04-19 | Takeda Gmbh | Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI0937074T1 (en) * | 1996-11-11 | 2003-08-31 | Altana Pharma Ag | Benzonaphthyridines as bronchial therapeutics |
| DK0968211T3 (da) * | 1997-03-07 | 2003-12-08 | Altana Pharma Ag | Tetrazolderivater |
| WO1998055481A1 (en) | 1997-06-03 | 1998-12-10 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
| ATE234301T1 (de) | 1998-05-05 | 2003-03-15 | Altana Pharma Ag | Neue benzonaphtyridin-n-oxide |
| EP1109810B1 (de) | 1998-08-31 | 2004-06-16 | ALTANA Pharma AG | Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität |
-
2002
- 2002-02-21 WO PCT/EP2002/001819 patent/WO2002066476A1/en not_active Ceased
- 2002-02-21 AU AU2002253045A patent/AU2002253045B2/en not_active Ceased
- 2002-02-21 SI SI200230083T patent/SI1377574T1/xx unknown
- 2002-02-21 AT AT02722110T patent/ATE287403T1/de active
- 2002-02-21 US US10/467,568 patent/US6936622B2/en not_active Expired - Fee Related
- 2002-02-21 EP EP02722110A patent/EP1377574B1/en not_active Expired - Lifetime
- 2002-02-21 CA CA2438717A patent/CA2438717C/en not_active Expired - Fee Related
- 2002-02-21 JP JP2002565990A patent/JP4248245B2/ja not_active Expired - Fee Related
- 2002-02-21 DK DK02722110T patent/DK1377574T3/da active
- 2002-02-21 ES ES02722110T patent/ES2236504T3/es not_active Expired - Lifetime
- 2002-02-21 PT PT02722110T patent/PT1377574E/pt unknown
- 2002-02-21 DE DE60202669T patent/DE60202669T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SI1377574T1 (cg-RX-API-DMAC10.html) | 2005-08-31 |
| JP2004526712A (ja) | 2004-09-02 |
| CA2438717A1 (en) | 2002-08-29 |
| ES2236504T3 (es) | 2005-07-16 |
| WO2002066476A1 (en) | 2002-08-29 |
| CA2438717C (en) | 2011-08-30 |
| DK1377574T3 (da) | 2005-04-25 |
| EP1377574B1 (en) | 2005-01-19 |
| AU2002253045B2 (en) | 2007-07-12 |
| ATE287403T1 (de) | 2005-02-15 |
| US20040097537A1 (en) | 2004-05-20 |
| DE60202669T2 (de) | 2005-09-15 |
| US6936622B2 (en) | 2005-08-30 |
| JP4248245B2 (ja) | 2009-04-02 |
| EP1377574A1 (en) | 2004-01-07 |
| DE60202669D1 (de) | 2005-02-24 |
| WO2002066476A9 (en) | 2003-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
| EA200301100A1 (ru) | Новые фталазиноны | |
| DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| WO2004018431A3 (en) | Novel phenanthridines | |
| DE60311662D1 (en) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
| PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
| MXPA02009567A (es) | Benzoilpirzoles y su uso como herbicidas. | |
| CY1105386T1 (el) | Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| MXPA03006224A (es) | Inhibidores de cruzipaina y otras proteasas de cisteina. | |
| GB0114185D0 (en) | Compounds | |
| ATE275544T1 (de) | Serinprotease-inhibitoren | |
| PT1086096E (pt) | Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4 | |
| SE0103710D0 (sv) | Compounds | |
| DE60202669D1 (de) | 6-phenylbenzonaphthyidine | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| EA200600607A1 (ru) | Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы | |
| SE9903290D0 (sv) | Novel compounds | |
| MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. | |
| EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
| MXPA06000372A (es) | Compuestos de silicio y su uso. | |
| EA200600608A1 (ru) | Производные имидазопиридина как ингибиторы индуцируемой no-синтазы | |
| ATE269313T1 (de) | Tryptase-inhibitoren | |
| ATE508130T1 (de) | 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren | |
| ATE348803T1 (de) | Tryptase-inhibitoren |